title: Genetic Testing and Neuroimaging: Trading off Benefit and Risk for Youth with Mental Illness.
abstract: According to the World Health Organization, mental illness is one of the leading causes of disability worldwide. The first onset of mental illness usually occurs during childhood or adolescence. Neuroimaging and genetic testing have been invaluable in research on behavioral and intentional disorders, particularly with their potential to lead to improved diagnostic and predictive capabilities and to decrease the associated burdens of disease. The present study focused specifically the perspectives of mental health providers on the role of neuroimaging and genetic testing in clinical practice with children and adolescents. We interviewed 38 psychiatrists, psychologists, and allied mental health professionals who work primarily with youth about their receptivity towards either the use of neuroimaging or genetic testing. Interviews probed the role they foresee for these modalities for prediction, diagnosis, and treatment planning, and the benefits and risks they anticipate. Practitioners anticipated three major benefits associated with clinical introduction of imaging and genetic testing in the mental health care for youth: (1) improved understanding of illness, (2) more accurate diagnosis than available through conventional clinical examination, and (3) validation of treatment plans. They also perceived three major risks: (1) potential adverse impacts on employment and insurance as adolescents reach adulthood, (2) misuse or misinterpretation of the imaging or genetic data, and (3) infringements on self-esteem or self-motivation. Movement of brain imaging and genetic testing into clinical care will require a delicate balance of biology and respect for autonomy in the still-evolving cognitive and affective world of young individuals.
authors.affiliation: Department of Medicine, University of British Columbia, Canada.
authors.forename: Grace
authors.initials: G
authors.lastname: Lee
authors.affiliation: Department of Medicine, University of British Columbia, Canada.
authors.forename: Ania
authors.initials: A
authors.lastname: Mizgalewicz
authors.affiliation: Center for Biomedical Ethics, Stanford University, USA.
authors.forename: Emily
authors.initials: E
authors.lastname: Borgelt
authors.affiliation: Department of Medicine, University of British Columbia, Canada.
authors.forename: Judy
authors.initials: J
authors.lastname: Illes
keywords: Child psychiatry; Ethics; Genetic testing; Mental health disorders; Neuroimaging